StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
269
This month
1
This week
1
This year
16
Today
1
Yesterday
1
Publishing Date
2024 - 02 - 22
2
2024 - 01 - 25
2
2023 - 11 - 02
2
2023 - 08 - 01
2
2023 - 05 - 25
2
2023 - 05 - 15
2
2023 - 04 - 14
3
2023 - 04 - 04
2
2023 - 02 - 07
2
2023 - 01 - 19
2
2022 - 11 - 01
2
2022 - 09 - 13
2
2022 - 08 - 15
2
2022 - 07 - 11
2
2022 - 05 - 31
2
2022 - 05 - 26
3
2022 - 05 - 09
4
2022 - 04 - 12
2
2022 - 03 - 25
3
2022 - 03 - 16
2
2022 - 02 - 14
2
2021 - 12 - 16
2
2021 - 11 - 12
2
2021 - 11 - 09
2
2021 - 10 - 21
2
2021 - 10 - 18
2
2021 - 10 - 12
2
2021 - 10 - 04
2
2021 - 09 - 22
2
2021 - 08 - 25
3
2021 - 08 - 06
2
2021 - 08 - 05
4
2021 - 08 - 03
2
2021 - 08 - 02
2
2021 - 07 - 20
2
2021 - 07 - 08
1
2021 - 06 - 28
1
2021 - 06 - 25
1
2021 - 06 - 10
1
2021 - 06 - 07
1
2021 - 05 - 14
1
2021 - 05 - 04
2
2021 - 05 - 03
3
2021 - 04 - 28
1
2021 - 04 - 27
1
2021 - 04 - 26
1
2021 - 04 - 19
2
2021 - 04 - 14
2
2021 - 03 - 29
1
2021 - 03 - 24
1
2021 - 03 - 22
1
2021 - 03 - 16
1
2021 - 03 - 03
1
2021 - 02 - 26
1
2021 - 01 - 21
1
2020 - 12 - 04
1
2020 - 10 - 14
1
2020 - 10 - 12
1
2020 - 09 - 30
1
2020 - 09 - 11
1
Sector
Commercial services
5
Communications
4
Consumer durables
2
Consumer non-durables
3
Consumer services
2
Electronic technology
3
Finance
2
Health services
2
Health technology
269
Manufacturing
23
N/a
9
Process industries
5
Producer manufacturing
3
Professional, scientific, and technical services
5
Technology services
4
Utilities
2
Tags
Alliances
7
Antibody
6
Application
6
Approval
11
Arct-154
5
Asco
3
Authorization
4
Awards
3
Biocapital
3
Biotech
5
Biotech-bay
10
Biotech-beach
17
Bleeding
3
Cabometyx
4
Cancer
29
Cell carcinoma
6
Clinical-trials-phase-ii
6
Clinical-trials-phase-iii
12
Collaboration
6
Covid
7
Covid-19
6
Disease
20
Drug
17
Earnings
18
Europe
4
Expected
6
Fda
5
Financial
16
Financial results
13
Gene therapies
5
Gene therapy
5
Genetown
6
Global
46
Growing
4
Growth
19
Japan
5
License
5
Liver
10
Market
79
N/a
152
Nivolumab
5
People
6
Pharmaceutical
4
Phase 2
5
Phase 3
13
Product-news
4
Rare
6
Reach
12
Renal
6
Report
40
Research
29
Results
46
Sars-cov-2
6
Set
4
Study
5
Therapeutics
36
Therapy
19
Treatment
33
Trial
21
Vaccine
16
Entities
Abbott laboratories
10
Abbvie inc.
29
Adma biologics inc
4
Adverum biotechnologies, inc.
2
Agios pharmaceuticals, inc.
2
Alnylam pharmaceuticals, inc.
2
Altria group
2
Amgen inc.
23
Amicus therapeutics, inc.
2
Arcturus therapeutics holdings inc.
26
Arrowhead pharmaceuticals, inc.
12
Astellas pharma inc
12
Astrazeneca plc
29
Avalonbay communities, inc.
2
Bausch health companies inc.
6
Baxter international inc.
4
Biocryst pharmaceuticals, inc.
2
Biogen inc.
6
Bristol-myers squibb company
43
Catalent, inc.
3
Centogene n.v.
5
Codexis, inc.
3
Csl ltd
4
Eli lilly and company
39
Exelixis, inc.
27
Genmab a/s
3
Gilead sciences, inc.
15
Glaxosmithkline plc
34
Global blood therapeutics, inc.
3
Grifols, s.a.
6
Hutchison china meditech limited
7
Immunogen, inc.
3
Incyte corporation
16
Jazz pharmaceuticals plc
6
Johnson & johnson
77
Karyopharm therapeutics inc.
7
Logicbio therapeutics, inc.
4
Macrogenics, inc.
4
Mallinckrodt plc
4
Moderna, inc.
5
Morphosys ag
13
Nektar therapeutics
3
Neurocrine biosciences, inc.
9
Novartis ag
58
Novavax, inc.
4
Novo nordisk a/s
15
Orange
4
Ovid therapeutics inc.
6
Pfizer, inc.
22
Regeneron pharmaceuticals, inc.
6
Sanofi
60
Takeda pharmaceutical company limited
269
Teva pharmaceutical industries limited
5
Teva pharmaceutical industries ltd
20
Thermo fisher scientific inc
5
Ucb s.a.
8
Vericel corporation
3
Vertex pharmaceuticals incorporated
4
Viatris inc.
7
Xencor, inc.
12
Symbols
AAPL
1198
ABB
1204
ABBV
608
ABLZF
1166
ABT
1074
ACAQ
522
AMGN
742
AMSIY
465
AMSYF
465
ARCXF
465
ARVL
4294
AVGO
593
AZN
665
BNPQF
1764
BNPQY
1764
CRCW
473
CSCO
897
DNZOF
504
DNZOY
504
ERIC
1612
EXTR
581
FNCTF
7191
FRBA
598
GE
508
GILD
500
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
811
HON
1026
IFNNF
531
IFNNY
509
INTC
955
JNJ
2072
LLY
1088
LTUM
971
MAR
474
MDT
731
MS
1788
MSFT
1201
MT
473
NIPNF
533
NOK
859
NOKBF
975
NVDA
517
NVS
1156
NVSEF
1031
ORCL
787
PCRFF
650
PCRFY
650
PHG
476
PPRUF
1128
PPRUY
1129
SAP
1379
SAPGF
1231
SNY
4539
SNYNF
3597
TEVJF
631
TMO
706
VSAC
534
Exchanges
Amex
1
Nasdaq
269
Nyse
421
Crawled Date
2024 - 02 - 22
2
2024 - 02 - 07
2
2024 - 01 - 25
2
2023 - 11 - 02
2
2023 - 11 - 01
2
2023 - 08 - 01
2
2023 - 05 - 25
2
2023 - 05 - 15
2
2023 - 04 - 14
3
2023 - 04 - 04
2
2023 - 02 - 07
2
2023 - 01 - 19
2
2022 - 11 - 01
2
2022 - 09 - 13
2
2022 - 08 - 15
2
2022 - 07 - 11
2
2022 - 05 - 31
2
2022 - 05 - 26
2
2022 - 05 - 09
4
2022 - 04 - 12
2
2022 - 03 - 25
3
2022 - 03 - 16
2
2022 - 02 - 14
2
2022 - 01 - 07
2
2021 - 12 - 16
2
2021 - 11 - 12
2
2021 - 11 - 09
2
2021 - 10 - 21
2
2021 - 10 - 12
2
2021 - 10 - 04
2
2021 - 09 - 22
2
2021 - 08 - 25
3
2021 - 08 - 06
2
2021 - 08 - 05
4
2021 - 08 - 03
2
2021 - 08 - 02
2
2021 - 07 - 20
2
2021 - 07 - 16
1
2021 - 07 - 08
1
2021 - 06 - 28
1
2021 - 06 - 25
1
2021 - 06 - 10
1
2021 - 06 - 07
1
2021 - 05 - 14
1
2021 - 05 - 04
2
2021 - 05 - 03
3
2021 - 04 - 28
1
2021 - 04 - 27
1
2021 - 04 - 26
1
2021 - 04 - 19
2
2021 - 04 - 15
1
2021 - 04 - 14
1
2021 - 03 - 29
1
2021 - 03 - 24
1
2021 - 03 - 22
1
2021 - 03 - 16
1
2021 - 03 - 04
5
2021 - 02 - 26
1
2021 - 01 - 21
1
2020 - 12 - 04
1
Crawled Time
00:00
13
00:20
1
01:00
12
02:00
8
04:00
2
04:20
1
05:00
3
07:00
1
08:00
4
09:00
9
10:00
6
10:48
5
11:00
15
12:00
29
12:15
3
12:20
1
12:30
1
13:00
21
13:15
2
13:20
1
13:30
3
14:00
14
14:02
1
14:15
1
14:20
5
14:30
3
15:00
10
15:15
2
15:20
2
15:30
2
16:00
4
17:00
11
18:00
13
19:00
10
20:00
8
20:20
1
21:00
9
22:00
20
23:00
12
Source
investors.ovidrx.com
6
www.biospace.com
116
www.fda.gov
1
www.globenewswire.com
19
www.prnewswire.com
127
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
TAK
exchanges :
Nasdaq
save search
Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published:
2024-04-19
(Crawled : 02:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
0.0%
|
O:
0.42%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.0%
|
O:
0.82%
H:
0.0%
C:
0.0%
MIRM
|
News
|
$23.83
1.1%
1.09%
340K
|
Health Technology
|
0.0%
|
O:
1.42%
H:
0.0%
C:
0.0%
report
million
reach
treatment
market
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Published:
2024-03-19
(Crawled : 11:00)
- globenewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-9.68%
|
O:
-0.07%
H:
0.0%
C:
-0.96%
CNTG
|
$0.463
0.43%
0.43%
79K
|
Commercial Services
|
-31.41%
|
O:
1.43%
H:
1.41%
C:
-1.41%
partnership
genetic
takeda
disorders
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.3%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.15%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.85%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-1.31%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.4%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.03%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-6.03%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.43%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
Plasma Therapy Global Market Report 2024 - Projected Compound Annual Growth Rate of 12.5%, with Market Set to Reach $0.88 Billion in 2028
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.79%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-5.99%
|
O:
-0.38%
H:
0.14%
C:
-0.14%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-15.22%
|
O:
2.0%
H:
2.28%
C:
1.63%
ADMA
4
|
$6.27
1.13%
1.12%
3.4M
|
Health Technology
|
19.69%
|
O:
0.19%
H:
2.5%
C:
1.35%
report
reach
global
set
therapy
growth
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
6.54%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
25.87%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-16.01%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.79%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.24%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.58%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
0.65%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.13%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.33%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.44%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.88%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-6.54%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Albumin Market to Reach $9.9 billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published:
2024-02-15
(Crawled : 15:00)
- prnewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-1.65%
|
O:
3.61%
H:
0.0%
C:
-0.13%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-2.79%
|
O:
-0.18%
H:
1.09%
C:
0.24%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-9.56%
|
O:
-0.83%
H:
0.38%
C:
0.0%
reach
research
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$563.5
-19.1%
6
|
Health Technology
|
12.7%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
9.56%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$55.65
0.02%
32K
|
Professional, Scientific, and T...
|
15.41%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-1.04%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.3%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.08%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-4.32%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
1.05%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
0.2%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.33%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.49%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.43%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
News
|
$29.095
0.64%
0.64%
87K
|
Health Technology
|
-25.19%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.85%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.79%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Published:
2024-02-13
(Crawled : 19:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.11%
|
O:
0.14%
H:
0.35%
C:
0.07%
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-7.02%
|
O:
-3.56%
H:
2.91%
C:
-3.34%
MOR
|
News
|
$17.96
-0.5%
-0.5%
180K
|
Health Technology
|
4.15%
|
O:
-0.4%
H:
0.23%
C:
-0.46%
MGNX
|
$15.62
-2.8%
-2.88%
1M
|
Health Technology
|
-10.16%
|
O:
-5.25%
H:
2.94%
C:
2.18%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-8.68%
|
O:
3.8%
H:
1.1%
C:
-1.17%
financial
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
12.13%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.11%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.41%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.44%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.58%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
1.83%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-2.91%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-4.57%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
|
-25.59%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.63%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.49%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-8.91%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-8.68%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-20.26%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.16%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$360.11
0.47%
0.47%
330K
|
Health Technology
|
-5.61%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-10.02%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024
Published:
2024-02-07
(Crawled : 12:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.13%
|
O:
0.07%
H:
0.42%
C:
0.07%
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
-6.81%
|
O:
-5.57%
H:
6.04%
C:
0.96%
financial
results
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-13.72%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.09%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
37.02%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-14.23%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.13%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-10.28%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.93%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
6.49%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-1.95%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.43%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.09%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.19%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-14.12%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.83%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-16.18%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
United States Endometrial Cancer Research Report 2023
Published:
2024-02-02
(Crawled : 10:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.55%
|
O:
0.21%
H:
0.49%
C:
-0.9%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-11.63%
|
O:
-0.5%
H:
0.26%
C:
-1.03%
report
cancer
research
Announcing Cognizant Flowsource™, a generative AI-enabled platform for powering modern engineering
Published:
2024-02-01
(Crawled : 05:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-9.93%
|
O:
0.48%
H:
0.0%
C:
-1.98%
CTSH
|
$67.4
0.4%
0.4%
4.9M
|
Technology Services
|
-11.92%
|
O:
0.3%
H:
0.78%
C:
0.69%
cognizant
platform
Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.
Published:
2024-01-26
(Crawled : 15:30)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.12%
|
O:
-0.27%
H:
0.38%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-13.0%
|
O:
0.29%
H:
0.15%
C:
-0.13%
SRPT
|
$115.53
-0.88%
-0.9%
640K
|
Health Technology
|
-1.77%
|
O:
0.69%
H:
0.12%
C:
-1.75%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-16.61%
|
O:
0.0%
H:
0.35%
C:
-0.88%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-14.61%
|
O:
0.1%
H:
0.47%
C:
0.39%
market
Cognizant Helping to Modernize Infrastructure and Application Management as Part of Takeda's Digital Transformation
Published:
2024-01-25
(Crawled : 22:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.12%
|
O:
-0.27%
H:
0.38%
C:
0.07%
CTSH
|
$67.4
0.4%
0.4%
4.9M
|
Technology Services
|
-13.24%
|
O:
0.33%
H:
0.42%
C:
-1.63%
management
cognizant
application
Exelixis Announces Detailed Results of Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer Presented at ASCO GU 2024
Published:
2024-01-25
(Crawled : 22:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.42%
|
O:
-0.27%
H:
0.07%
C:
-0.07%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
4.14%
|
O:
0.14%
H:
1.4%
C:
-0.23%
ntact-02
asco
cancer
trial
results
Immunoglobulin Market to Reach $25.6 Billion, Globally, by 2032 at 6.6% CAGR: Allied Market Research
Published:
2023-12-14
(Crawled : 00:00)
- prnewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-7.34%
|
O:
-1.89%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.07%
|
O:
-0.07%
H:
0.18%
C:
-0.64%
GRFS
|
News
|
$6.29
-3.82%
-3.97%
1.2M
|
Health Technology
|
-37.65%
|
O:
0.95%
H:
2.27%
C:
1.98%
reach
research
market
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-22.28%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.34%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.34%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-23.82%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.61%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
28.63%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.97%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.07%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
27.99%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.71%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
11.75%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.46%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.29%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.35%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
Insomnia Therapeutics Market to grow by USD 1 billion from 2022-2027 | North America to account for 60% of market growth - Technavio
Published:
2023-11-27
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.28%
|
O:
-1.89%
H:
0.02%
C:
0.02%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-23.82%
|
O:
-4.49%
H:
6.23%
C:
3.42%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
19.06%
|
O:
-0.21%
H:
0.21%
C:
-1.93%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.54%
|
O:
-0.07%
H:
0.28%
C:
0.21%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
3.59%
|
O:
-0.24%
H:
0.03%
C:
-0.39%
VNDA
|
$5.11
2.82%
2.74%
2.4M
|
Health Technology
|
47.19%
|
O:
2.81%
H:
0.0%
C:
-3.01%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.49%
|
O:
-1.41%
H:
0.87%
C:
0.0%
america
therapeutics
growth
market
COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published:
2023-11-06
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
17.51%
|
O:
0.41%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
20.74%
|
O:
0.11%
H:
0.33%
C:
-0.98%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
45.64%
|
O:
0.22%
H:
1.49%
C:
-0.33%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-4.08%
|
O:
0.44%
H:
0.22%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-0.4%
|
O:
0.24%
H:
0.18%
C:
0.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.43%
|
O:
0.18%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
13.83%
|
O:
0.55%
H:
0.3%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
11.32%
|
O:
-0.42%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.36%
|
O:
-1.32%
H:
0.0%
C:
0.0%
covid-19
← Previous
1
2
3
4
5
6
7
8
9
…
13
14
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.